
Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Swiss venture capital vehicle backing longevity and mental health biotechnology companies

Korify Capital AG is a venture capital investment vehicle. It backs breakthrough technologies in longevity and mental health, and its portfolio is made up mainly of biotechnology companies.
Portfolio companies named on its site include Alto, which matches patients to psychiatric treatments using AI-derived brain biomarkers, Cambrian, which builds therapeutics aimed at lengthening healthspan, and Refoxy, which develops medicines for age-related disease by targeting FOXO modulators. The firm also publishes news from other portfolio businesses.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Korify Capital AG.
Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications
Everything here links back to the same verified catalogue. Pick your next stop.